SCHEMBL18812367

SCHEMBL18812367

CC(C)COc1ccc(-c2cccnc2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.65
CYP3A4 P08684 3/20 0.65
CYP2C9 P11712 2/20 0.65
CYP2C19 P33261 2/20 0.65
CYP2D6 P10635 1/20 0.65
CYP11B2 P19099 4/20 0.52
ALDH1A1 P00352 3/20 0.52
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
CYP11B1 P15538 2/20 0.52
KDM4E B2RXH2 2/20 0.52
HPGD P15428 2/20 0.52
LMNA P02545 1/20 0.52
TSHR P16473 1/20 0.52
HSD17B10 Q99714 1/20 0.52
AAK1 Q2M2I8 2/20 0.50
CYP17A1 P05093 2/20 0.49
CYP2A6 P11509 3/20 0.48
CYP1A2 P05177 1/20 0.48
S1PR1 P21453 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10035355 0.84 SMN1; SMN2 (0.55) CYP19A1CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL21156862 0.83 CYP19A1 (0.73) CYP19A1CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL10338918 0.81 CYP19A1 (0.76) CYP19A1CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL2608833 0.81 CHRNB2 (0.58)
SCHEMBL14672093 0.81 MAPT (0.57) CYP3A4CYP2C9CYP2C19ALDH1A1NPC1
SCHEMBL20851318 0.80 MAPT (0.58) CYP3A4CYP2C9CYP2C19ALDH1A1NPC1
SCHEMBL16108295 0.79 KMO (0.51) CYP19A1CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL14129887 0.79 CYP2D6 (1.00) CYP19A1CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL31140254 0.77 CYP2C9 (0.65) CYP19A1CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL31140250 0.77 CYP2C9 (0.65) CYP19A1CYP3A4CYP2C9CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11794180-B2 Tri-(adamantyl)phosphines and applications thereof THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2023-10-24 US disclosed
US-20230158480-A1 TRI-(ADAMANTYL)PHOSPHINES AND APPLICATIONS THEREOF UNIV PRINCETON (US) 2023-05-25 US disclosed
WO-2017075581-A1 TRI-(ADAMANTYL)PHOSPHINES AND APPLICATIONS THEREOF THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2017-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11794180-B2 Tri-(adamantyl)phosphines and applications thereof PADI3, ADA, ENTPD3 CYP19A1 2835/4885CYP3A4 1515/4885CYP2C9 1260/4885
US-20230158480-A1 TRI-(ADAMANTYL)PHOSPHINES AND APPLICATIONS THEREOF PADI3, ADA, ENTPD3 CYP19A1 2835/4885CYP3A4 1515/4885CYP2C9 1260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.